Literature DB >> 12516782

The 78 kDa glucose-regulated protein (GRP78/BIP) is expressed on the cell membrane, is released into cell culture medium and is also present in human peripheral circulation.

Andrea Delpino1, Mauro Castelli.   

Abstract

In human rabdomiosarcoma cells (TE671/RD) chronic exposure to 500 nM thapsigargin (a powerful inhibitor of the endoplasmic reticulum Ca2+-ATPases) resulted in the induction of the stress protein GRP78/BIP. Making use of the surface biotinylation method, followed by the isolation of the GRP78 using ATP-agarose affinity chromatography, it was found that a fraction of the thapsigargin-induced GRP78 is expressed on the cell surface. The presence of GRP78 on the membrane of thapsigargin-treated cells was confirmed by fractionation of cell lysates into a soluble and a membrane fraction, followed by Western blot analysis with an anti-GRP78 antibody. It was also found that conspicuous amounts of GRP78 are present in the culture medium collected from thapsigargin-treated cultures. This extracellular GRP78 originates mostly by an active release from intact cells and does not result solely from the leakage of proteins from dead cells. Moreover, small amounts of circulating, free GRP78 and naturally-occurring anti-GRP78 autoantibodies were detected in the peripheral circulation of healthy human individuals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12516782     DOI: 10.1023/a:1020966008615

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  59 in total

1.  Expression and distribution of grp-78/bip in mineralizing tissues and mesenchymal cells.

Authors:  Sriram Ravindran; Qi Gao; Amsaveni Ramachandran; Premanand Sundivakkam; Chinnaswamy Tiruppathi; Anne George
Journal:  Histochem Cell Biol       Date:  2012-04-17       Impact factor: 4.304

Review 2.  Extracellular heat shock proteins: a new location, a new function.

Authors:  Antonio De Maio; Daniel Vazquez
Journal:  Shock       Date:  2013-10       Impact factor: 3.454

Review 3.  Dentin sialophosphoprotein and dentin matrix protein-1: Two highly phosphorylated proteins in mineralized tissues.

Authors:  Shigeki Suzuki; Naoto Haruyama; Fusanori Nishimura; Ashok B Kulkarni
Journal:  Arch Oral Biol       Date:  2012-04-24       Impact factor: 2.633

4.  Localization of GRP78 to mitochondria under the unfolded protein response.

Authors:  Fang-Chun Sun; Shou Wei; Chia-Wei Li; Yuo-Sheng Chang; Chih-Chung Chao; Yiu-Kay Lai
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

Review 5.  Stress protein-polypeptide complexes acting as autoimmune triggers.

Authors:  P Eggleton
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 6.  Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?

Authors:  A M Shields; G S Panayi; V M Corrigall
Journal:  Clin Exp Immunol       Date:  2011-06-14       Impact factor: 4.330

7.  GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.

Authors:  Gidi Shani; Wolfgang H Fischer; Nicholas J Justice; Jonathan A Kelber; Wylie Vale; Peter C Gray
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

8.  Comparative proteomic study between human normal motility sperm and idiopathic asthenozoospermia.

Authors:  Shulin Shen; Jinzi Wang; Jihong Liang; Dalin He
Journal:  World J Urol       Date:  2013-03-02       Impact factor: 4.226

9.  Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers.

Authors:  Vaishali Kapoor; David Y A Dadey; Kim Nguyen; Scott A Wildman; Kelly Hoye; Arpine Khudanyan; Nilantha Bandara; Buck E Rogers; Dinesh Thotala; Dennis E Hallahan
Journal:  J Nucl Med       Date:  2016-07-21       Impact factor: 10.057

10.  Intraluminal blockade of cell-surface CD74 and glucose regulated protein 78 prevents substance P-induced bladder inflammatory changes in the rat.

Authors:  Pedro L Vera; Xihai Wang; Richard J Bucala; Katherine L Meyer-Siegler
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.